Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Faculty, Dental | 2 | 2025 | 4 | 1.160 |
Why?
|
| Parkinson Disease | 5 | 2024 | 134 | 1.060 |
Why?
|
| Dental Care | 2 | 2025 | 9 | 1.020 |
Why?
|
| Attitude of Health Personnel | 4 | 2025 | 585 | 0.880 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2025 | 755 | 0.860 |
Why?
|
| Mandatory Reporting | 2 | 2020 | 18 | 0.800 |
Why?
|
| Child Care | 2 | 2020 | 19 | 0.790 |
Why?
|
| Retirement | 1 | 2022 | 18 | 0.770 |
Why?
|
| Child Abuse | 2 | 2020 | 90 | 0.730 |
Why?
|
| Plasma Exchange | 1 | 2020 | 22 | 0.680 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2020 | 35 | 0.670 |
Why?
|
| Education, Distance | 1 | 2020 | 34 | 0.640 |
Why?
|
| Attitude | 1 | 2020 | 100 | 0.630 |
Why?
|
| Dental Caries | 1 | 2019 | 26 | 0.630 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2019 | 37 | 0.600 |
Why?
|
| Cognitive Dysfunction | 1 | 2022 | 330 | 0.570 |
Why?
|
| Antihypertensive Agents | 1 | 2019 | 171 | 0.550 |
Why?
|
| Medication Adherence | 1 | 2019 | 196 | 0.550 |
Why?
|
| Religion and Psychology | 1 | 2016 | 12 | 0.530 |
Why?
|
| Family | 3 | 2019 | 240 | 0.520 |
Why?
|
| Cognition | 2 | 2022 | 481 | 0.510 |
Why?
|
| Blood Pressure | 1 | 2019 | 513 | 0.510 |
Why?
|
| Middle Aged | 22 | 2025 | 17363 | 0.490 |
Why?
|
| Sports | 1 | 2016 | 97 | 0.490 |
Why?
|
| Female | 32 | 2025 | 32488 | 0.470 |
Why?
|
| Patient Education as Topic | 1 | 2019 | 462 | 0.470 |
Why?
|
| Male | 29 | 2025 | 29483 | 0.470 |
Why?
|
| Psychometrics | 2 | 2016 | 377 | 0.460 |
Why?
|
| Aged | 21 | 2024 | 14254 | 0.450 |
Why?
|
| Quality of Life | 4 | 2019 | 1221 | 0.430 |
Why?
|
| Adult | 19 | 2025 | 16625 | 0.420 |
Why?
|
| Hypertension | 1 | 2019 | 590 | 0.420 |
Why?
|
| Oral Health | 3 | 2025 | 64 | 0.410 |
Why?
|
| Humans | 40 | 2025 | 62678 | 0.410 |
Why?
|
| Motor Activity | 1 | 2015 | 343 | 0.390 |
Why?
|
| Stress, Psychological | 1 | 2016 | 469 | 0.380 |
Why?
|
| Young Adult | 10 | 2024 | 4633 | 0.360 |
Why?
|
| Aged, 80 and over | 10 | 2019 | 5406 | 0.340 |
Why?
|
| Attitude to Health | 2 | 2010 | 291 | 0.330 |
Why?
|
| Health Surveys | 1 | 2011 | 312 | 0.320 |
Why?
|
| Exercise | 1 | 2016 | 937 | 0.320 |
Why?
|
| Amyotrophic Lateral Sclerosis | 4 | 2016 | 507 | 0.320 |
Why?
|
| Schizophrenic Psychology | 1 | 2009 | 68 | 0.310 |
Why?
|
| Brain Injuries | 1 | 2011 | 140 | 0.310 |
Why?
|
| Critical Illness | 2 | 2010 | 321 | 0.310 |
Why?
|
| Life Expectancy | 1 | 2009 | 34 | 0.300 |
Why?
|
| Adolescent | 8 | 2020 | 6172 | 0.300 |
Why?
|
| Cross-Sectional Studies | 5 | 2025 | 2540 | 0.290 |
Why?
|
| China | 4 | 2022 | 169 | 0.290 |
Why?
|
| Pain Management | 3 | 2021 | 163 | 0.280 |
Why?
|
| New York | 2 | 2025 | 144 | 0.280 |
Why?
|
| Advance Care Planning | 2 | 2018 | 63 | 0.270 |
Why?
|
| Prenatal Care | 2 | 2025 | 173 | 0.250 |
Why?
|
| Internet | 4 | 2022 | 463 | 0.240 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2024 | 28 | 0.230 |
Why?
|
| Pregnancy | 4 | 2025 | 2316 | 0.220 |
Why?
|
| Longitudinal Studies | 3 | 2024 | 1247 | 0.210 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2024 | 72 | 0.210 |
Why?
|
| Pain | 2 | 2016 | 406 | 0.200 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2024 | 213 | 0.200 |
Why?
|
| Friends | 1 | 2022 | 28 | 0.190 |
Why?
|
| Child | 4 | 2020 | 4444 | 0.190 |
Why?
|
| Weight Reduction Programs | 1 | 2022 | 58 | 0.190 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 166 | 0.190 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2024 | 348 | 0.180 |
Why?
|
| Analgesia, Epidural | 1 | 2021 | 28 | 0.180 |
Why?
|
| Analgesia, Obstetrical | 1 | 2021 | 23 | 0.180 |
Why?
|
| Labor, Obstetric | 1 | 2021 | 38 | 0.170 |
Why?
|
| Plasmapheresis | 1 | 2020 | 18 | 0.170 |
Why?
|
| Surveys and Questionnaires | 3 | 2025 | 2648 | 0.170 |
Why?
|
| Lenses, Intraocular | 1 | 2020 | 7 | 0.170 |
Why?
|
| Phacoemulsification | 1 | 2020 | 9 | 0.170 |
Why?
|
| Lens Implantation, Intraocular | 1 | 2020 | 9 | 0.170 |
Why?
|
| Lens, Crystalline | 1 | 2020 | 17 | 0.170 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 161 | 0.170 |
Why?
|
| Cataract Extraction | 1 | 2020 | 37 | 0.160 |
Why?
|
| Cataract | 1 | 2020 | 54 | 0.160 |
Why?
|
| Gonioscopy | 1 | 1999 | 4 | 0.160 |
Why?
|
| Microscopy, Acoustic | 1 | 1999 | 2 | 0.160 |
Why?
|
| Anterior Chamber | 1 | 1999 | 5 | 0.160 |
Why?
|
| Pamphlets | 1 | 2019 | 17 | 0.160 |
Why?
|
| Smoking Cessation | 1 | 2024 | 551 | 0.160 |
Why?
|
| Pennsylvania | 1 | 2019 | 64 | 0.150 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2019 | 24 | 0.150 |
Why?
|
| Neuropsychological Tests | 3 | 2011 | 389 | 0.150 |
Why?
|
| Cognition Disorders | 2 | 2011 | 220 | 0.150 |
Why?
|
| Factor Analysis, Statistical | 2 | 2009 | 98 | 0.150 |
Why?
|
| Self Efficacy | 2 | 2017 | 202 | 0.150 |
Why?
|
| Severity of Illness Index | 4 | 2016 | 1541 | 0.150 |
Why?
|
| Pain Measurement | 2 | 2016 | 343 | 0.140 |
Why?
|
| Inpatients | 1 | 2020 | 302 | 0.140 |
Why?
|
| Terminal Care | 1 | 2018 | 103 | 0.140 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2016 | 44 | 0.130 |
Why?
|
| Codeine | 1 | 2016 | 5 | 0.130 |
Why?
|
| Social Facilitation | 1 | 2016 | 5 | 0.130 |
Why?
|
| Bulbar Palsy, Progressive | 1 | 2016 | 4 | 0.130 |
Why?
|
| Antitussive Agents | 1 | 2016 | 12 | 0.130 |
Why?
|
| Time Factors | 3 | 2019 | 3742 | 0.120 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 1077 | 0.120 |
Why?
|
| Patient Selection | 1 | 2018 | 482 | 0.120 |
Why?
|
| United States | 4 | 2024 | 7719 | 0.120 |
Why?
|
| Child, Preschool | 2 | 2019 | 1937 | 0.120 |
Why?
|
| Parenting | 1 | 2016 | 72 | 0.120 |
Why?
|
| Self Care | 1 | 2017 | 212 | 0.120 |
Why?
|
| Research Design | 1 | 2018 | 572 | 0.120 |
Why?
|
| Psychotic Disorders | 1 | 2016 | 160 | 0.110 |
Why?
|
| Polymorphism, Genetic | 2 | 2011 | 189 | 0.110 |
Why?
|
| Disease Management | 1 | 2016 | 234 | 0.110 |
Why?
|
| Decision Making | 1 | 2017 | 402 | 0.110 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 313 | 0.100 |
Why?
|
| Parents | 1 | 2017 | 381 | 0.100 |
Why?
|
| Reproducibility of Results | 4 | 2011 | 1638 | 0.100 |
Why?
|
| Art | 1 | 2012 | 2 | 0.100 |
Why?
|
| APACHE | 2 | 2010 | 45 | 0.100 |
Why?
|
| Asthma | 1 | 2017 | 433 | 0.100 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 432 | 0.100 |
Why?
|
| Geriatrics | 1 | 2012 | 43 | 0.100 |
Why?
|
| Treatment Outcome | 3 | 2019 | 5590 | 0.100 |
Why?
|
| Receptors, Opioid, mu | 1 | 2011 | 15 | 0.090 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2011 | 2 | 0.090 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2011 | 21 | 0.090 |
Why?
|
| Antipyretics | 1 | 2010 | 1 | 0.090 |
Why?
|
| Alcohol-Related Disorders | 1 | 2011 | 38 | 0.090 |
Why?
|
| Ibuprofen | 1 | 2010 | 18 | 0.090 |
Why?
|
| Smoking | 1 | 2016 | 864 | 0.090 |
Why?
|
| Mood Disorders | 1 | 2011 | 72 | 0.090 |
Why?
|
| Fever | 1 | 2010 | 66 | 0.090 |
Why?
|
| Awareness | 1 | 2011 | 75 | 0.090 |
Why?
|
| Self Concept | 1 | 2011 | 111 | 0.090 |
Why?
|
| Education, Medical | 1 | 2012 | 182 | 0.080 |
Why?
|
| Acetaminophen | 1 | 2010 | 59 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 2445 | 0.080 |
Why?
|
| Linear Models | 1 | 2011 | 409 | 0.080 |
Why?
|
| Students, Medical | 1 | 2012 | 255 | 0.080 |
Why?
|
| Primary Dysautonomias | 1 | 2009 | 7 | 0.080 |
Why?
|
| Intensive Care Units | 2 | 2010 | 405 | 0.080 |
Why?
|
| Dementia | 1 | 2012 | 258 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 208 | 0.080 |
Why?
|
| Substance-Related Disorders | 1 | 2016 | 716 | 0.070 |
Why?
|
| Alcoholism | 1 | 2011 | 319 | 0.070 |
Why?
|
| Mental Processes | 1 | 2008 | 18 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2009 | 576 | 0.070 |
Why?
|
| Single-Blind Method | 2 | 2017 | 144 | 0.070 |
Why?
|
| Reference Values | 2 | 2021 | 335 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2024 | 3258 | 0.060 |
Why?
|
| Synaptotagmins | 1 | 2024 | 7 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2011 | 2539 | 0.060 |
Why?
|
| Transplantation, Autologous | 1 | 2024 | 126 | 0.060 |
Why?
|
| Motor Cortex | 1 | 2024 | 72 | 0.060 |
Why?
|
| Prognosis | 1 | 2009 | 1724 | 0.060 |
Why?
|
| Transplantation, Homologous | 1 | 2024 | 244 | 0.050 |
Why?
|
| Students | 2 | 2016 | 217 | 0.050 |
Why?
|
| Vaping | 1 | 2024 | 44 | 0.050 |
Why?
|
| Tissue Donors | 1 | 2024 | 153 | 0.050 |
Why?
|
| Patient Acuity | 1 | 2022 | 22 | 0.050 |
Why?
|
| Feedback | 1 | 2022 | 89 | 0.050 |
Why?
|
| Parity | 1 | 2021 | 72 | 0.040 |
Why?
|
| Logistic Models | 2 | 2016 | 1273 | 0.040 |
Why?
|
| Minority Groups | 1 | 2021 | 139 | 0.040 |
Why?
|
| Weight Loss | 1 | 2022 | 272 | 0.040 |
Why?
|
| Eye, Artificial | 1 | 2020 | 1 | 0.040 |
Why?
|
| Visual Acuity | 1 | 2020 | 126 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2020 | 184 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2021 | 422 | 0.040 |
Why?
|
| Risk Factors | 3 | 2015 | 5302 | 0.040 |
Why?
|
| Advance Directives | 1 | 2017 | 48 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 109 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 3387 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2022 | 685 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2021 | 1341 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2017 | 86 | 0.030 |
Why?
|
| Vocational Education | 1 | 2016 | 4 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 317 | 0.030 |
Why?
|
| Behavior Control | 1 | 2016 | 16 | 0.030 |
Why?
|
| Age of Onset | 1 | 2016 | 175 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 212 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 775 | 0.030 |
Why?
|
| Smoking Prevention | 1 | 2016 | 162 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 497 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2016 | 393 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2015 | 285 | 0.030 |
Why?
|
| Obesity | 1 | 2022 | 1230 | 0.030 |
Why?
|
| Adolescent Behavior | 1 | 2016 | 193 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2016 | 739 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2015 | 294 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2017 | 476 | 0.020 |
Why?
|
| Comorbidity | 1 | 2015 | 1118 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2011 | 119 | 0.020 |
Why?
|
| Prevalence | 1 | 2015 | 1348 | 0.020 |
Why?
|
| Agnosia | 1 | 2011 | 4 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2011 | 242 | 0.020 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2011 | 24 | 0.020 |
Why?
|
| Problem Solving | 1 | 2011 | 31 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 2011 | 46 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2011 | 65 | 0.020 |
Why?
|
| Mice | 1 | 2024 | 10802 | 0.020 |
Why?
|
| Alleles | 1 | 2011 | 445 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 299 | 0.020 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2015 | 708 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 649 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2011 | 768 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2011 | 562 | 0.020 |
Why?
|
| Sialorrhea | 1 | 2009 | 1 | 0.020 |
Why?
|
| PubMed | 1 | 2009 | 10 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 463 | 0.020 |
Why?
|
| Constipation | 1 | 2009 | 16 | 0.020 |
Why?
|
| Deglutition Disorders | 1 | 2009 | 43 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 862 | 0.020 |
Why?
|
| Bipolar Disorder | 1 | 2011 | 246 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2011 | 254 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2011 | 987 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2011 | 1110 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2008 | 148 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 714 | 0.020 |
Why?
|
| Language | 1 | 2008 | 143 | 0.020 |
Why?
|
| Animals | 1 | 2024 | 20579 | 0.020 |
Why?
|
| Infant | 1 | 2010 | 1602 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2016 | 6535 | 0.010 |
Why?
|